| |
| |
|
| Insider
Information: |
Duggan Robert W |
| Relationship: |
Chief Executive Office... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
594,894,754 |
|
|
Indirect Shares
|
1,046,059 |
|
|
| Direct
Value |
$2,866,937,379 |
|
|
|
Indirect Value
|
$10,078,051 |
|
|
| Total
Shares |
595,940,813 |
|
|
| Total
Value |
$2,877,015,430 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
19
|
0
|
|
Stock
price went up :
|
5
|
0
|
| Stock
price went down : |
14
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -0.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Intuitive Surgical Inc |
ISRG |
Director |
2011-05-18 |
1,000 |
2011-02-09 |
0 |
Premium* |
|
|
Pharmacyclics Inc |
PCYC |
Chairman and CEO, Dire... |
2015-05-26 |
0 |
2015-05-26 |
0 |
Premium* |
|
|
Pulse Biosciences, Inc. |
PLSE |
Director, 10% Owner |
2023-12-12 |
36,984,179 |
2023-12-12 |
843,634 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
2019-03-20 |
5,555,414 |
2019-03-20 |
202,425 |
Premium* |
|
|
Summit Therapeutics Inc |
SMMT |
Chief Executive Office... |
2023-03-06 |
552,354,161 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
318 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 12 of 13
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-29 |
4 |
B |
$9.44 |
$1,497,184 |
D/D |
158,600 |
36,551,461 |
3.92 |
% |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-08-21 |
4 |
B |
$1.60 |
$265,667 |
D/D |
166,042 |
4,997,299 |
3.92 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-06-06 |
4 |
A |
$1.63 |
$278,782 |
D/D |
171,032 |
4,574,397 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-09-14 |
4 |
B |
$11.66 |
$2,409,935 |
D/D |
181,620 |
3,569,314 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-09-15 |
4 |
B |
$14.38 |
$3,000,710 |
D/D |
197,098 |
3,766,412 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chairman and CEO |
• • • |
2014-12-05 |
5 |
D |
$0.00 |
$0 |
I/I |
(200,740) |
170,379 |
0 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-04-20 |
4 |
B |
$13.23 |
$2,860,421 |
D/D |
216,150 |
6,818,419 |
2.45 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-11-20 |
4 |
B |
$1.93 |
$446,947 |
D/D |
231,495 |
8,263,770 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
– • • |
2018-12-13 |
4 |
OE |
$12.57 |
$2,915,818 |
I/I |
232,044 |
267,044 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2007-02-21 |
4 |
B |
$2.98 |
$775,491 |
D/D |
250,381 |
3,907,956 |
2.45 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2019-03-18 |
4 |
S |
$0.56 |
$152,252 |
D/D |
(271,879) |
6,561,423 |
0 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-12-11 |
4 |
B |
$1.65 |
$505,010 |
D/D |
306,848 |
9,187,309 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chairman and CEO |
• • • |
2015-05-26 |
4 |
D |
$261.25 |
$95,553,494 |
I/I |
(365,755) |
0 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
– • • |
2020-12-29 |
4 |
OE |
$7.01 |
$2,636,216 |
D/D |
376,065 |
11,659,781 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2006-11-08 |
4 |
B |
$4.75 |
$1,854,000 |
D/D |
390,000 |
2,862,956 |
2.45 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-03-01 |
4 |
B |
$10.33 |
$4,243,285 |
D/D |
410,606 |
6,108,358 |
2.45 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-12-10 |
4 |
B |
$1.60 |
$697,789 |
D/D |
436,500 |
8,880,461 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-06-05 |
4 |
A |
$1.38 |
$655,467 |
D/D |
474,976 |
4,403,365 |
0 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2019-03-11 |
4 |
S |
$0.63 |
$327,664 |
D/D |
(520,102) |
8,667,207 |
0 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2019-03-12 |
4 |
S |
$0.61 |
$386,725 |
D/D |
(633,975) |
8,033,232 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2007-02-21 |
4 |
B |
$2.58 |
$1,831,467 |
D/D |
654,619 |
3,657,575 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chairman & CEO |
• • • |
2011-06-21 |
4 |
B |
$8.85 |
$6,000,300 |
D/D |
678,000 |
12,081,244 |
3.23 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-05-03 |
4 |
B |
$11.31 |
$9,579,477 |
D/D |
846,625 |
8,027,627 |
2.45 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2019-03-19 |
4 |
S |
$0.53 |
$506,685 |
D/D |
(956,009) |
5,605,414 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chairman and CEO |
• • • |
2010-06-21 |
4 |
B |
$6.51 |
$6,999,995 |
D/D |
1,075,268 |
10,904,702 |
3.23 |
- |
|
318 Records found
|
|
Page 12 of 13 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
